Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-13-000226
Filing Date
2013-02-14
Accepted
2013-02-14 15:49:24
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2012-12-31 aoxing10q.htm 10-Q 575991
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A). aoxing10qexh311.htm EX-31.1 10141
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A). aoxing10qexh312.htm EX-31.2 9092
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxing10qexh321.htm EX-32.1 5200
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxing10qexh322.htm EX-32.2 5295
  Complete submission text file 0001096906-13-000226.txt   3077519

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE axn-20121231.xml EX-101.INS 398923
7 XBRL SCHEMA axn-20121231.xsd EX-101.SCH 30018
8 XBRL CALCULATION axn-20121231_cal.xml EX-101.CAL 19657
9 XBRL DEFINITION axn-20121231_def.xml EX-101.DEF 105461
10 XBRL LABEL axn-20121231_lab.xml EX-101.LAB 145496
11 XBRL PRESENTATION axn-20121231_pre.xml EX-101.PRE 135207
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 13613245
SIC: 2834 Pharmaceutical Preparations